Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.45
-0.38 (-5.56%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Harvard Bioscience Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$18.00
Upside
+179.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $0.6 → $6 | Buy | Maintains | $0.6 → $6 | -6.98% | Mar 16, 2026 |
| Benchmark | Benchmark | Buy Maintains $2 → $0.6 | Buy | Maintains | $2 → $0.6 | -90.70% | Mar 13, 2026 |
| Benchmark | Benchmark | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +210.08% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $45 → $30 | Buy | Maintains | $45 → $30 | +365.12% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $55 → $45 | Buy | Maintains | $55 → $45 | +597.67% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $70 | Buy | Reiterates | $70 | +985.27% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $40 → $70 | Strong Buy | Maintains | $40 → $70 | +985.27% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $50 → $70 | Buy | Maintains | $50 → $70 | +985.27% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +520.16% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $70 → $50 | Buy | Maintains | $70 → $50 | +675.19% | Nov 9, 2022 |
| Keybanc | Keybanc | Buy Maintains $100 → $70 | Buy | Maintains | $100 → $70 | +985.27% | Aug 5, 2022 |
| Keybanc | Keybanc | Buy Initiates $60 | Buy | Initiates | $60 | +830.23% | Nov 10, 2020 |
| Benchmark | Benchmark | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +520.16% | Feb 27, 2020 |
| Benchmark | Benchmark | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +1,140.31% | Jul 28, 2015 |